The Middle East & Africa injectable drug delivery market is projected to reach USD 22.54 billion by 2031 from USD 16.46 billion in 2026, growing at a CAGR of 6.5% during the forecast period. This drives the demand for biologics, vaccines, biosimilars, and long-acting injectables across the Middle East & Africa region, thereby boosting growth in the injectable drug delivery market. The prominent injectable drug delivery device manufacturers are BD (US), B. Braun SE (Germany), Terumo Corporation (Japan), Baxter (US), Cardinal Health (US), among others. The injectable drug delivery formulation manufacturers in the Middle East & Africa are Sanofi (France), Novartis AG (Switzerland), Pfizer Inc. (US), GSK plc (UK), and Hikma Pharmaceuticals PLC (UK), among others. Market Ranking (Device Manufacturers)The top injectable drug delivery device companies in the Middle East & Africa are BD (US), B. Braun SE (Germany), Terumo Corporation (Japan), Baxter (US), and Cardinal Health (US).

Source: The North Africa Journal February 16, 2026 13:28 UTC